Abstract
Brain slices from 20-day-old rats were incubated with [3H]palmitate for 2 hours in the absence or presence of the NO-donors S-nitroso-N-acetyl-penicillamine (SNAP), ethyl-2-[hydroxyimino]-5-nitro-3-hexeneamide (NOR-3), 4-phenyl-3-furoxan carbonitrile (PFC) and sodium nitroprusside (SNP). Each of these drugs reduced the incorporation of [3H]palmitate into myelin proteolipid protein (PLP) in a concentration-dependent manner, SNP being the most active. The effect of SNAP was prevented by the NO-scavenger PTIO (2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide). Furthermore, decayed-SNAP, sodium nitrite and N- nitrosopyrrolidine were inactive, suggesting that free NO and/or some of its direct oxidation products are the active molecular species. The amount of fatty acids bound to PLP and the rate of deacylation were unaffected by NO. Although NO diminished the number of thiols in brain and myelin proteins, with the formation of both nitrosothiols and disulfides, these changes did not parallel those in PLP acylation. In contrast, NO was effective at reducing the palmitoylation of brain and myelin lipids, and this effect along with that of PLP, was ascribed to a decrease in palmitoyl-CoA levels. The NO-induced reduction in acyl-CoA concentration was due to the decline in ATP levels, while the amount of [3H]palmitate incorporated into the tissue, the activity of palmitoyl-CoA ligase and palmitoyl-CoA hydrolase, and the concentration of CoASH were unaltered by the drugs. Experiments with endogenously-synthesized [18O]fatty acids confirmed that NO affects predominantly the ATP-dependent palmitoylation of PLP. In conclusion, the inhibitory action of NO on the fatty acylation of PLP is indirect and caused by energy depletion.
Similar content being viewed by others
REFERENCES
Ross N.W. and Braun, P. E. 1988. Acylation in vitro of the myelin proteolipid protein and comparison with acylation in vivo: acylation of a cysteine occurs nonenzymatically. J. Neurosci. Res. 21:35–44.
Bizzozero O. A. and Good L. K. 1990. Myelin proteolipid protein contains thioester-linked fatty acids. J. Neurochem. 55:1986–1992.
Weimbs, T. and Stoffel W. 1992. Proteolipid protein (PLP) of CNS myelin: positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP. Biochemistry 31:12289–12296.
Townsend L. E., Agrawal D., Benjamins J. A., and Agrawal H. C. 1982. In vitro acylation of rat brain myelin proteolipid protein. J. Biol. Chem. 257:9745–9750.
Townsend L. E. and Benjamins J. A. 1983. Effects of monensin on posttranslational processing of myelin proteins. J. Neurochem. 40:1333–1339.
Bizzozero O. A., Soto E. F., and Pasquini J. M. 1983. Myelin proteolipid protein is not esterified at the site of synthesis. Neurochem. Int. 5:729–736.
Pasquini J. M., Bizzozero O. A., Besio-Moreno M., and Soto E. F. 1987. Effects of calcium and cobalt ions on the transfer of proteins to the myelin membrane. Neurochem. Inter. 11:17–22.
Bizzozero O. A., McGarry J. F., and Lees M. B. 1987. Autoacylation of myelin proteolipid protein with acyl-CoA. J. Biol. Chem. 262:13550–13557.
Bizzozero O. A., Leyba, J., and Nuñez D. J. 1992. Characterization of proteolipid protein fatty acylesterase from rat brain myelin. J. Biol. Chem. 267:7886–7894.
Bizzozero O. A., Sanchez P., and Tetzloff S. U. 1999. Effect of ATP-depletion on the palmitoylation of myelin proteolipid protein in young and adult rats. J. Neurochem. 72:2610–2616.
Tetzloff S. U. and Bizzozero O. A. 1998. Palmitoylation of proteolipid protein from rat brain myelin using endogenously-generated 18O-fatty acids. J. Biol. Chem. 273:279–285.
Bizzozero O. A., Bixler H. A., Davis J., Espinosa A., and Messier A. M. 2001. Chemical deacylation reduces the adhesive properties of proteolipid protein and leads to decompaction of the myelin sheath. J. Neurochem. 76:1129–1141.
Moncada S., Palmer R., and Higgs E. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:109–142.
Butler A., Flitney, W., and Williams D. 1995. Nitric oxide, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemist's perspective. Trends Pharmacol. Sci. 16:18–22.
Beckman J. 1996. The physiological and pathological chemistry of nitric oxide. pp. 1–82 in Nitric Lancaster J. (ed.) Oxide: Principles and Actions Academic Press, San Diego, California.
Wang Y., Newton D. C., and Marsden, P. A. 1999. Neuronal NOS: gene structure, mRNA diversity, and functional relevance. Crit. Rev. Neurobiol. 13:21–43.
Licinio J., Prolo P., McCann S., and Wong M. L. 1999. Brain iNOS: current understanding and clinical implications. Mol. Med. Today 5:225–232.
Hess D., Patterson S., Smith D., and Skene J. 1993. Neuronal growth cone collapse and inhibition of protein acylation by nitric oxide. Nature 366:562–565.
Baker T. L., Booden M. A., and Buss J. E. 2000. S-nitrosocysteine increases palmitate turnover on Ha-Ras in NIH 3T3 cells. J. Biol. Chem. 275:22037–22047.
Adam L., Bouvier M., and Jones T. L. Z. 1999. Nitric oxide modulates β2-adrenergic receptor palmitoylation and signaling. J. Biol. Chem. 274:26337–26343.
Bo L., Dawson T., Wasswlingh S., Mork S., Choi S., Kong P. A., Hanley D., and Trapp B. D. 1994. Induction of nitric oxide synthetase in demyelinating regions of MS brains. Ann. Neurol. 36:778–786.
Bagasra O., Michaels F., Zheng Y., Bobroski L., Spitsin S., Fu Z., Tawadros R., and Koprowski H. 1995. Activation of the inducible form of nitric oxide synthetase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. 92:12041–12045.
Johnson W., Land J., Thompson E., Bolanos J. P., Clark J. B., and Heales S. J. 1995. Evidence for increased nitric oxide production in multiple sclerosis. Neurol. Neurosurg. Psychiatry 58:107.
Koprowski H., Zheng Y., Heber-Katz E., Fraser N., Rorke L., Fu Z., Hanlon B., and Dietzschold, B. 1993. In vivo expression of inducible nitric oxide synthetase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. 90:3024–3027.
Lin R., Lin T., Tilton R., and Cross A. 1993. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study. J. Exp. Med. 178:643–648.
Okuda Y., Nakatsuji H., Fujimura H., Esumi H., Ogura T., Yanagihara T., and Sakoda S. 1995. Expression of the inducible form of nitric oxide synthetase in the central nervous system of mice with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62:103–111.
Norton W. T. and Poduslo S. E. 1973. Myelination in rat brain: method of myelin isolation. J. Neurochem. 21:749–757.
Bizzozero O. A., Besio-Moreno M., Pasquini J. M., Soto E. F., and Gomez C. J. 1982. Rapid purification of proteolipids from rat brain subcellular fractions by chromatography on a lipophillic dextran gel. J. Chromatog. 227:33–44.
Messier A. M. and Bizzozero O. A. 2000. Conserved fatty acid composition of proteolipid protein during brain development and in myelin subfractions. Neurochem. Res. 24:449–455.
Sanchez P., Tetzloff S. U., and Bizzozero O. A. 1998. Veratridine-induced depolarization reduces the palmitoylation of brain and myelin glycerolipids. J. Neurochem. 70:1448–1457.
Riddles P. W., Blakely R. L., and Zerner B. 1979. Ellman's reagent: 5,5′-dithiobis(2-nitrobenzoic acid)-a reexamination. Anal. Biochem. 94:75–81.
Berge R. K. and Farstad M. 1981. Long-chain fatty acyl-CoA hydrolase from rat liver mitochondria. Methods Enzymol. 71:234–242.
Vaswani K. K. and Ledeen R. W. 1987. Long-chain acyl-coenzyme A synthetase in rat brain myelin. J. Neurosci. Res. 17:65–70.
Tubbs P. K. and Garland P. B. 1969. Assay of coenzyme A and some acyl derivatives. Methods Enzymol. 13:535–551.
Titheradge M. A. 1998. The enzymatic measurement of nitrate and nitrite. Meth. Molc. Bio. 100:83–91.
Saville B. 1958. A scheme for the colorimetric determination of microgram amounts of thiols. Analyst (London) 83:670–672.
Crow J. and Ischiropoulos H. 1996. Detection and quantitation of nitrotyrosine residues in proteins: in vivo marker of peroxynitrite. Methods Enzymol. 269:185–194.
Akaike T., Yoshida M., Miyamoto Y., Sato K., Kohno M., Sasamoto K., Miyazaki K., Ueda S., and Maeda H. 1993. Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor through a radical reaction. Biochemistry 32:827–832.
Radi R., Beckman J., Bush K., and Freeman B. 1991. Peroxy-nitrite-mediated sulfhydryl oxidation: the cytotoxic potential of superoxide and nitrogen oxide. J. Biol. Chem. 266:4244–4250.
Stamler J. S. 1994. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78:931–936.
Grange E., Deutsch J., Smith Q. R., Chang M., Rapaport S. I., and Purdon A. D. 1995. Specific activity of brain palmitoyl-CoA pool provides rates of incorporation of palmitate in brain phospholipids in awake rats. J. Neurochem. 65:2290–2298.
Curran R. D., Ferrari F. K., Kispert P. H., Stadler, J., Stuehr D. J., Simmons R. L., and Billiar T. R. 1991. Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J. 5:2085–2092.
Stadler, J., Curran R. D., Ochoa J. B., Harbrecht B. G., Hoffman, R. A., Simmons R. L., and Billiar T. R. 1991. Effect of endogenous nitric oxide on mitochondrial respiration of rat hepatocytes in vitro and in vivo. Arch. Surg. 126:186–191.
Dimmeler L., Lottspeich F., and Brüne B. 1992. Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 267:16771–16774.
Drapier J. C. and Hibbs J. B. 1986. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells: inhibition involves the iron-sulfur prosthetic group and is reversible. J. Clin. Invest. 78:790–797.
Lizasoain U., Moro M., Knowles R., Darley V., and Moncada S. 1996. Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione and glucose. Biochem. J. 314:877–880.
Bolaños J., Peuchen, D., Heales, S., Land J. M., and Clark J. B. 1994. Nitric oxide mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J. Neurochem. 63:910–916.
Bolaños J. P., Almeida A., Stewart V., Peuchen, S., Land, J. M., Clark, J. B., and Heales, S. J. 1997. Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J. Neurochem. 68:2227–2240.
Zhang, J., Dawson, V. L., Dawson, T. M., and Snyder S. H. 1994. Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity. Science 263:687–689.
Erecinska M., Neldon D., and Vanderkooi J. M. 1995. Effects of NO-generating compounds on synaptosomal energy metabolism. J. Neurochem. 65:2699–2705.
Brorson J. R., Schumacker P. T., and Zhang H. 1999. Nitric oxide acutely inhibits neuronal energy production. J. Neurosci. 19:147–158.
Kapur S., Picard F., Perreault M., Deshaies Y., and Marette A. 2000. Nitric oxide: a new player in the modulation of energy metabolism. Int. J. Obes. Relat. Metab. Disord. 24:S36–S40.
Feelisch M. 1991. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J. Cardiovasc. Pharmacol. 17:S25–S33.
Singh, R. J., Hogg, N., Joseph J., and Kalyanaraman B. 1996. Mechanism of nitric oxide release from S-nitrosothiols. J. Biol. Chem. 271:18596–18603.
Kita Y., Hirasawa Y., Maeda, K., Nishio M., and Yoshida K. 1994. Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409. Eur. J. Pharmacol. 257:123–130.
Medana C., Ermondi G., Fruttero R., Di Stilo A., Ferretti C., and Gasco A. 1994. Furoxans as nitric oxide donors-4-Phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluation. J. Med. Chem. 37:4412–4416.
Ferioli R., Folco G. C., Ferretti C., Gasco A. M., Medana C., Fruttero R., Civelli M., and Gasco A. 1995. A new class of furoxan derivatives as NO donors: mechanism of action and biological activity. Br. J. Pharmacol. 114:816–820.
Terwel D., Nieland, L. J., Schutte B., Reutelingsperger C. P., Ramaekers F. C., and Steinbusch H. W. 2000. S-nitroso-Nacetylpenicillamine and nitroprusside induce apoptosis in a neuronal cell line by the production of different reactive molecules. Eur. J. Pharmacol. 14:19–33.
Boullerne A. I., Nedelkoska L., and Benjamins J. A. 1999. Synergism of nitric oxide and iron in killing the transformed murine oligodendrocyte cell line N20.1. J. Neurochem. 72:1050–1060.
Fukuto J. M. 1995. Chemistry of nitric oxide: biologically relevant aspects. Adv. Pharmacol. 34:1–15.
Bar-tana J., Rose G., and Shapiro B. 1975. Long-chain fatty acyl-CoA synthetase from rat liver microsomes. Methods Enzymol. 35:117–122.
Abou-Issa H. M. and Cleland, W. W. 1969. Studies on microsomal acylation of L-glycerol-3 phosphate. Biochim. Biophys. Acta 176:692–698.
Miki Y., Hosaka K., Yamashita S., Handa H., and Numa S. 1977. Acyl-acceptor specificities of 1-acylglycerol phosphate and 1-acylglycerophosphorylcholine acyltransferase from rat liver microsomes. Eur. J. Biochem. 81:433–441.
Hess D., Lin L., Freeman, J., and Norden J. 1994. Modification of cysteine residues in Go and other neuronal proteins by exposure to nitric oxide. Neuropharmacol. 33:1283–1292.
Yeh D. C., Duncan, J. A., Yamashita S., and Michel T. 1999. Depalmitoylation of endothelial nitric-oxide synthase by acylprotein thioesterase 1 is potentiated by Ca(2+)-calmodulin. J. Biol. Chem. 274:33148–33154.
Malinski T., Bailey F. Zhang Z. G., and Chopp M. 1993. Nitric oxide measured by a porphyrinic microsensor in rat brain after middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 13:355–358.
Tominaga T., Sato S., Ohmishi T., and Ohmishi S. T. 1994. Electron paramagnetic resonance (EPR) detection of nitric oxide produced during forebrain ischemia in the rat. J. Cereb. Blood Flow Metab. 14:715–722.
Hooper D. C., Ohnishi, S. T., Kean R., Numagami Y., Dietzschold B., and Koprowski H. 1995. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. 92:5312–5316.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bizzozero, O.A., Bixler, H., Parkhani, J. et al. Nitric Oxide Reduces the Palmitoylation of Rat Myelin Proteolipid Protein by an Indirect Mechanism. Neurochem Res 26, 1127–1137 (2001). https://doi.org/10.1023/A:1012370822754
Issue Date:
DOI: https://doi.org/10.1023/A:1012370822754